Zhang Yan-Jin, Stein David A, Fan Su-Min, Wang Kai-Yu, Kroeker Andrew D, Meng Xiang-Jin, Iversen Patrick L, Matson David O
Center for Pediatric Research, Eastern Virginia Medical School, Norfolk, VA 23510, USA.
Vet Microbiol. 2006 Oct 31;117(2-4):117-29. doi: 10.1016/j.vetmic.2006.06.006. Epub 2006 Jul 12.
Porcine reproductive and respiratory syndrome virus (PRRSV) is the causative agent of a contagious disease characterized by reproductive failure in sows and respiratory disease in piglets. This infectious disease results in significant losses in the swine industry and specific anti-PRRSV drugs are needed. In this study, we evaluated a novel class of antisense compounds, peptide-conjugated phosphorodiamidate morpholino oligomers (P-PMOs), for their ability to suppress PRRSV replication in cell culture. P-PMOs are analogs of single-stranded DNA and contain a modified backbone that confers highly specific binding to RNA and resistance to nucleases. Of six P-PMOs tested, one ('5UP1'), with sequence complementary to the 5'-terminal 21 nucleotides of the PRRSV genome, was found to be highly effective at reducing PRRSV replication in a specific and dose-dependent manner in CRL11171 cells in culture. 5UP1 treatment generated up to a 4.5log reduction in infectious PRRSV yield, while a control P-PMO had no effect on viral titer. Immunofluorescence assay with an anti-PRRSV monoclonal antibody confirmed the titer observations. The sequence-specificity of 5UP1 effect was confirmed in part by a cell-free luciferase reporter assay system, which showed that 5UP1-mediated inhibition of translation decreased if the target-RNA contained mispairings in relation to the 5UP1 P-PMO. Real-time RT-PCR showed that the production of PRRSV negative-sense RNA was reduced if 5UP1 was added to cells at up to 6h post-virus inoculation. Cell viability assays detected no cytotoxicity of 5UP1 within the concentration-range of this study. These results indicate that P-PMO 5UP1 has potential as an anti-PRRSV agent.
猪繁殖与呼吸综合征病毒(PRRSV)是一种传染病的病原体,其特征是母猪繁殖失败和仔猪呼吸道疾病。这种传染病给养猪业造成了重大损失,因此需要特效抗PRRSV药物。在本研究中,我们评估了一类新型反义化合物,即肽缀合的磷二酰胺吗啉代寡聚物(P-PMO),在细胞培养中抑制PRRSV复制的能力。P-PMO是单链DNA的类似物,其修饰的骨架使其能够与RNA高度特异性结合并抵抗核酸酶。在所测试的六种P-PMO中,有一种(“5UP1”),其序列与PRRSV基因组5'-末端的21个核苷酸互补,发现在培养的CRL11171细胞中,它能以特异性和剂量依赖性方式高效降低PRRSV复制。5UP1处理使感染性PRRSV产量降低了高达4.5个对数,而对照P-PMO对病毒滴度没有影响。用抗PRRSV单克隆抗体进行的免疫荧光测定证实了滴度观察结果。无细胞荧光素酶报告基因检测系统部分证实了5UP1作用的序列特异性,该系统表明,如果靶RNA与5UP1 P-PMO存在错配,则5UP1介导的翻译抑制作用会降低。实时RT-PCR显示,如果在病毒接种后6小时内向细胞中加入5UP1,PRRSV负链RNA的产生会减少。细胞活力测定在本研究的浓度范围内未检测到5UP1的细胞毒性。这些结果表明,P-PMO 5UP1有潜力成为一种抗PRRSV药物。